Dexcom anticipates $5.20B-$5.25B 2026 revenue while authorizing another $1B buyback
Dexcom anticipates $5.20B-$5.25B 2026 revenue while authorizing another $1B buyback（摘要待生成）
DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise Zacks Investment Research
Dexcom (DXCM) Q3 2026 Earnings Call Transcript
Dexcom (DXCM) Q3 2026 Earnings Call Transcript（摘要待生成）
DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance（摘要待生成）
DexCom Slides as Investors Appear to Take Risk Off Ahead of Earnings | DXCM Stock News
DexCom Slides as Investors Appear to Take Risk Off Ahead of Earnings Quiver Quantitative
Raymond James raises DexCom stock price target to $97 on U.S. growth
Raymond James raises DexCom stock price target to $97 on U.S. growth Investing.com
DexCom (DXCM) Shares Fall 6.5% Amid Broader Market Gains on Octo - GuruFocus
DexCom (DXCM) Shares Fall 6.5% Amid Broader Market Gains on Octo GuruFocus
Dexcom schedules October 29 results for Dexcom stock
Dexcom schedules October 29 results for Dexcom stock AD HOC NEWS
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin（摘要待生成）
Mizuho raised Dexcom price target to $100 from $95; Buy maintained
On October 13, 2026, Mizuho analyst Anthony Petrone raised his DXCM target to $100 from $95 and maintained Buy. The stock closed at $85.06 that day, down 1.0% from October 12’s $85.92 close.